Has Mitchell Engle received payments from drug or device companies?

Yes. Drug and device makers reported $1,476,184 in general payments to Mitchell Engle across 988 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mitchell Engle did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mitchell Engle come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mitchell Engle

Pain Medicine · Houston, TXNPI 1790946051

Payments from drug & device makers

$1,476,184in general payments, 2019–2025

Across 988 payments — averaging $1494.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Nalu Medical, Inc.$692K
Boston Scientific$308K
Nevro Corp.$180K
SPR Therapeutics, Inc$176K
Globus Medical$94K
Mesoblast, Inc.$18K
plus $8K from 37 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Nalu Medical, Inc.	147	$692,459
Boston Scientific	502	$307,539
Nevro Corp.	49	$180,192
SPR Therapeutics, Inc	31	$176,029
Globus Medical	13	$94,415
Mesoblast, Inc.	5	$17,639
Vertos Medical, Inc.	8	$1,818
Abbott	78	$1,157
Relievant Medsystems, Inc.	6	$1,005
Saluda Medical Americas, Inc.	18	$834
Medtronic(2 entities)	30	$714
Teva Pharmaceuticals USA, Inc.	11	$229
Curonix LLC	2	$189
Collegium Pharmaceutical, Inc.	13	$188
Spinefrontier, Inc.	1	$182
AbbVie	3	$170
MML US, Inc.	2	$126
Amgen(2 entities)	8	$115
Supernus Pharmaceuticals, Inc.	8	$111
Biohaven Pharmaceuticals, Inc.	5	$110
Averitas Pharma Inc.	4	$88
Pfizer	4	$77
Lilly USA, LLC	4	$71
Spinesmith Holdings, LLC	1	$69
Vertex	3	$64
Xtant Medical Inc	1	$63
Tersera Therapeutics LLC	3	$60
Vertiflex, Inc.	2	$52
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	3	$48
Fidia Pharma USA Inc.	4	$45
Arbor Pharmaceuticals, Inc.	3	$44
GRT US Holding, Inc.	2	$36
Merz Pharmaceuticals, LLC	1	$34
Stratus Medical, LLC	2	$31
Biotronik NRO, Inc.	1	$28
Radius Health, Inc.	2	$28
Redhill Biopharma Inc.	2	$25
Hikma Pharmaceuticals USA	1	$21
Johnson & Johnson	1	$20
Novartis	1	$19
AstraZeneca	1	$17
Biohaven Pharmaceutical Holding Company Ltd.	1	$12
Biodelivery Sciences International, Inc.	1	$11

How this compares

$1,476,184 in reported general payments places this provider in the 95th percentile of 583 pain medicine providers in Texas.

See all pain medicine providers in Texas →

Medicare billing

Part B allowed, 2024

$431,166

Medicare patients

652

Services billed

8,214

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pain medicine in Houston

Daniel PakHouston$460K
David LeimanHouston$281K
Grant ChenHouston$175K
Gunjan PatelHouston$166K
Jaideep MehtaHouston$161K
Mayur KanjiaHouston$46K
Baominh VinhHouston$44K
Matthew ChungHouston$26K
Aaron CalodneyTyler$3M
Melissa MurphyGrapevine$711K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →